SCM
NPTN

Sandler Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Sandler Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-273,270
Closed -$4.46M – 187
2016
Q3 		$4.46M Buy
+273,270
New +$3.85M 0.55% 67

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Sandler Capital Management's NPTN Position: Q4 2016 in Review

Sandler Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2016, closing a stake of 273,270 shares — an estimated $4.46M sold.

Sandler Capital Management first reported a position in NPTN in Q3 2016 and held it in 1 quarter. The position peaked at $4.46M in Q3 2016. 127 funds tracked by Wall St. Rank hold NPTN as of Q4 2016.

  • Sandler Capital Management reported no remaining NEOPHOTONICS CORP position as of Q4 2016 after selling out during the quarter.
  • Sandler Capital Management sold 273,270 NEOPHOTONICS CORP shares in Q4 2016, an estimated $4.46M.
  • Sandler Capital Management first reported a position in NEOPHOTONICS CORP in Q3 2016 and held it in 1 quarter.
  • Sandler Capital Management's NEOPHOTONICS CORP position peaked at $4.46M in Q3 2016.
  • 127 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2016.

Based on Sandler Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.